Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-ge... Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also involved in the development of INV043, which is in Phase II clinical trial for the treatment of patients with prostate cancer; and in Phase I/II clinical trial to treat non-melanoma skin cancer, as well as for the treatment of oesophageal cancer. The company has collaborations with Hudson Institute of Medical Research, Peter MacCallum Cancer Centre, Dr. I&B Co., Ltd., and Hanlim Pharm Co., Ltd. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0.004 | 0.004 | 0.004 | 375000 | 0.004 | DE |
| 12 | -0.009 | -69.2307692308 | 0.013 | 0.013 | 0.004 | 347192 | 0.00562731 | DE |
| 26 | -0.023 | -85.1851851852 | 0.027 | 0.033 | 0.004 | 231065 | 0.0118536 | DE |
| 52 | -0.021 | -84 | 0.025 | 0.04 | 0.004 | 280404 | 0.02239846 | DE |
| 156 | -0.021 | -84 | 0.025 | 0.04 | 0.004 | 280404 | 0.02239846 | DE |
| 260 | 0.001 | 33.3333333333 | 0.003 | 0.04 | 0.001 | 2438443 | 0.0043135 | DE |
rakp
25分前
Ridetherocket
27分前
DLEtest
35分前
Genz2
45分前
big bopper1
57分前
John543
1時間前
satter
1時間前
JimBoStevens
1時間前
WandererGolem241
1時間前
ExoticSuccess1582
2時間前
nwsun
2時間前
ChangnoiPlaza
2時間前
Lolo_Ferrari
2時間前
mdb1
2時間前
Genz2
2時間前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。